ArticleScientific reports2025
Privacy preservation in diabetic disease prediction using federated learning based on efficient cross stage recurrent model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Oxidative balance score as a predictor of MASLD-CVD comorbidity risk and mortality: Insights from traditional and machine learning approaches.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
- Data Privacy, Ownership, and Secondary Use of Clinical Data Generated by Continuous Glucose Monitors and Mobile Health Applications: A Review.Journal of diabetes science and technology · 2026Review
- Health-FedNet: secure federated learning for chronic disease prediction on MIMIC-III with differential privacy and homomorphic encryption.Scientific reports · 2026Article
- LSTCNet: timely prediction of influenza in China using Baidu index and LSTM-TCN hybrid network.BMC public health · 2026Article
- Advanced retinal disease detection using RHT-Net: a hybrid deep learning approach with augmented fundus imaging.Frontiers in physiology · 2026Article
- Predicting and classifying type 2 diabetes using a transparent ensemble model combining random forest, k-nearest neighbor, and neural networks.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a major problemfor the diabetes patients that makes a serious threat to vision and causes the irreversible blindness if not diagnosed and treated early. Conventional deep learning-based approaches designed for DR detection have demonstrated promising results; still, the requirement of centralized data aggregation makes privacy and security concerns for sharing the healthcare data. Thus, for providing the privacy preservation federated learning (FL) based methods were designed; still, the computation overhead and inaccurate detection of disease limits the performance. Hence, this research introduces a privacy-preserving framework named federated learning based diabetic retinopathy detection network (FedDRNet) model. The proposed FedDRNet model includes efficient cross stage recurrent network (ECSRNet) for training the local and server model that combines the strengths of ShuffleNet, CSPNet, and GRU to achieve high accuracy and computational efficiency. Besides, to strengthen the privacy, Homomorphic Encryption is applied prior to the update sharing for obtaining secure communication between clients and the central server. Also, improved K-means clustering (IKMC) based user selection enhances the communication efficiency by reducing the communication rounds. The analysis of FedDRNet by implementing in PYTHON programming tool based on Accuracy, Precision, Recall, F-Score, and Specificity acquired the values of 98.6, 98.8, 98.3, 98.6, and 98.1% respectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.